Cargando…

Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease

Patients with alcoholic liver disease (ALD) often display disturbed iron indices. Hepcidin, a key regulator of iron metabolism, has been shown to be down-regulated by alcohol in cell lines and animal models. This down-regulation led to increased duodenal iron transport and absorption in animals. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Dostalikova-Cimburova, Marketa, Balusikova, Kamila, Kratka, Karolina, Chmelikova, Jitka, Hejda, Vaclav, Hnanicek, Jan, Neubauerova, Jitka, Vranova, Jana, Kovar, Jan, Horak, Jiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196659/
https://www.ncbi.nlm.nih.gov/pubmed/24894955
http://dx.doi.org/10.1111/jcmm.12310
_version_ 1782339512830001152
author Dostalikova-Cimburova, Marketa
Balusikova, Kamila
Kratka, Karolina
Chmelikova, Jitka
Hejda, Vaclav
Hnanicek, Jan
Neubauerova, Jitka
Vranova, Jana
Kovar, Jan
Horak, Jiri
author_facet Dostalikova-Cimburova, Marketa
Balusikova, Kamila
Kratka, Karolina
Chmelikova, Jitka
Hejda, Vaclav
Hnanicek, Jan
Neubauerova, Jitka
Vranova, Jana
Kovar, Jan
Horak, Jiri
author_sort Dostalikova-Cimburova, Marketa
collection PubMed
description Patients with alcoholic liver disease (ALD) often display disturbed iron indices. Hepcidin, a key regulator of iron metabolism, has been shown to be down-regulated by alcohol in cell lines and animal models. This down-regulation led to increased duodenal iron transport and absorption in animals. In this study, we investigated gene expression of duodenal iron transport molecules and hepcidin in three groups of patients with ALD (with anaemia, with iron overload and without iron overload) and controls. Expression of DMT1, FPN1, DCYTB, HEPH, HFE and TFR1 was measured in duodenal biopsies by using real-time PCR and Western blot. Serum hepcidin levels were measured by using ELISA. Serum hepcidin was decreased in patients with ALD. At the mRNA level, expressions of DMT1, FPN1 and TFR1 genes were significantly increased in ALD. This pattern was even more pronounced in the subgroups of patients without iron overload and with anaemia. Protein expression of FPN1 paralleled the increase at the mRNA level in the group of patients with ALD. Serum ferritin was negatively correlated with DMT1 mRNA. The down-regulation of hepcidin expression leading to up-regulation of iron transporters expression in the duodenum seems to explain iron metabolism disturbances in ALD. Alcohol consumption very probably causes suppression of hepcidin expression in patients with ALD.
format Online
Article
Text
id pubmed-4196659
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-41966592014-12-03 Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease Dostalikova-Cimburova, Marketa Balusikova, Kamila Kratka, Karolina Chmelikova, Jitka Hejda, Vaclav Hnanicek, Jan Neubauerova, Jitka Vranova, Jana Kovar, Jan Horak, Jiri J Cell Mol Med Original Articles Patients with alcoholic liver disease (ALD) often display disturbed iron indices. Hepcidin, a key regulator of iron metabolism, has been shown to be down-regulated by alcohol in cell lines and animal models. This down-regulation led to increased duodenal iron transport and absorption in animals. In this study, we investigated gene expression of duodenal iron transport molecules and hepcidin in three groups of patients with ALD (with anaemia, with iron overload and without iron overload) and controls. Expression of DMT1, FPN1, DCYTB, HEPH, HFE and TFR1 was measured in duodenal biopsies by using real-time PCR and Western blot. Serum hepcidin levels were measured by using ELISA. Serum hepcidin was decreased in patients with ALD. At the mRNA level, expressions of DMT1, FPN1 and TFR1 genes were significantly increased in ALD. This pattern was even more pronounced in the subgroups of patients without iron overload and with anaemia. Protein expression of FPN1 paralleled the increase at the mRNA level in the group of patients with ALD. Serum ferritin was negatively correlated with DMT1 mRNA. The down-regulation of hepcidin expression leading to up-regulation of iron transporters expression in the duodenum seems to explain iron metabolism disturbances in ALD. Alcohol consumption very probably causes suppression of hepcidin expression in patients with ALD. Blackwell Publishing Ltd 2014-09 2014-06-03 /pmc/articles/PMC4196659/ /pubmed/24894955 http://dx.doi.org/10.1111/jcmm.12310 Text en © 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Dostalikova-Cimburova, Marketa
Balusikova, Kamila
Kratka, Karolina
Chmelikova, Jitka
Hejda, Vaclav
Hnanicek, Jan
Neubauerova, Jitka
Vranova, Jana
Kovar, Jan
Horak, Jiri
Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
title Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
title_full Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
title_fullStr Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
title_full_unstemmed Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
title_short Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
title_sort role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196659/
https://www.ncbi.nlm.nih.gov/pubmed/24894955
http://dx.doi.org/10.1111/jcmm.12310
work_keys_str_mv AT dostalikovacimburovamarketa roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT balusikovakamila roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT kratkakarolina roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT chmelikovajitka roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT hejdavaclav roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT hnanicekjan roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT neubauerovajitka roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT vranovajana roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT kovarjan roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease
AT horakjiri roleofduodenalirontransportersandhepcidininpatientswithalcoholicliverdisease